CD200R1 and Alzheimer disease: Clinically, downregulation of CD200R1 has been observed in the cerebrospinal fluid of patients with AD and delirium (Peters van Ton et al., 2020), and neuronal CD200 expression negatively correlates with hallmark AD pathologies including neurofibrillary tangles and amyloid plaques (Walker et al., 2017).